» Articles » PMID: 32989469

Tolerability and Psychological Effects of a Multimodal Day-care Rehabilitation Program for Persons with Huntington's Disease

Overview
Journal J Rehabil Med
Date 2020 Sep 29
PMID 32989469
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine whether the psychological benefits of intense, inpatient, multimodal rehabilitation for persons with Huntingtons disease (HD), as found in earlier studies, also apply in a shorter, day-care setting.

Design: Prospective, non-randomized cohort study.

Subjects: Twenty patients attending a group-based 8-week (3 days/week) rehabilitation programme aimed at persons in early stages of HD.

Methods: An explorative cohort study on register data from a specialized rehabilitation centre, includ-ing descriptive data, number of cancellations, a self-reported evaluation, and measures of psychiatric symptoms, health-related quality of life, sense of coherence and physical function at baseline and at the end of rehabilitation.

Results: Patients' attendance rate was almost 90%. Patients were satisfied, and displayed significantly reduced anxiety and depression and improved health-related quality of life after rehabilitation. Baseline measures of sense of coherence showed significant negative correlation with the number of cancelled days of rehabilitation. Physical function improved, but did not correlate significantly with psychological outcome measures.

Conclusion: These results indicate that an 8-week multimodal day-care rehabilitation programme can be tolerable, reduce psychiatric symptoms, and improve health-related quality of life for people with HD. A higher sense of coherence seems to promote attendance rates. Further larger studies, including the impact of cognition and disease progression on the treatment effect, are warranted.

Citing Articles

A scoping review of health literacy in rare disorders: key issues and research directions.

Stenberg U, Westfal L, Dybesland Rosenberger A, Orstavik K, Flink M, Holmen H Orphanet J Rare Dis. 2024; 19(1):328.

PMID: 39243094 PMC: 11380335. DOI: 10.1186/s13023-024-03332-5.


Evidence-Based Review on Symptomatic Management of Huntington's Disease.

Shin J, Yang H, Ahn J, Jo S, Chung S, Lee J J Mov Disord. 2024; 17(4):369-386.

PMID: 39117301 PMC: 11540544. DOI: 10.14802/jmd.24140.


Update of Rehabilitation in Huntington's Disease: Narrative Review.

Kim K, Song M Brain Neurorehabil. 2023; 16(3):e28.

PMID: 38047100 PMC: 10689859. DOI: 10.12786/bn.2023.16.e28.


Quality of life, health-related quality of life, and associated factors in Huntington's disease: a systematic review.

van Lonkhuizen P, Frank W, Heemskerk A, van Duijn E, de Bot S, Muhlback A J Neurol. 2023; 270(5):2416-2437.

PMID: 36715747 PMC: 10129943. DOI: 10.1007/s00415-022-11551-8.

References
1.
Thompson J, Cruickshank T, Penailillo L, Lee J, Newton R, Barker R . The effects of multidisciplinary rehabilitation in patients with early-to-middle-stage Huntington's disease: a pilot study. Eur J Neurol. 2012; 20(9):1325-9. DOI: 10.1111/ene.12053. View

2.
Guyatt G, Sullivan M, Thompson P, Fallen E, Pugsley S, Taylor D . The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985; 132(8):919-23. PMC: 1345899. View

3.
Dumas E, van den Bogaard S, Middelkoop H, Roos R . A review of cognition in Huntington's disease. Front Biosci (Schol Ed). 2013; 5(1):1-18. DOI: 10.2741/s355. View

4.
Craufurd D, Thompson J, Snowden J . Behavioral changes in Huntington Disease. Neuropsychiatry Neuropsychol Behav Neurol. 2001; 14(4):219-26. View

5.
Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View